Minaris Regenerative Medicine’s leaders and experts are proud to share their knowledge and insight with the cell and gene therapy industry. Please review our current and past blog posts on topics of interest to this emerging industry.
A technology transfer (“tech transfer”) for cell therapy manufacturing is the transfer of knowledge, experience, specifications, procedures, and data for manufacture of ...
In a recent article, we discussed some of the major telltale signs that your cell therapy product might not be ready for a technology transfer. To be successful, a cell ...
Maintaining a sterile environment is an absolute must for maintaining product sterility in cell therapy manufacturing. Although the cost of building cleanrooms has ...
Product stewardship is a vital part of any cell therapy technology transfer and/or clinical development. The basic definition of product stewardship is the technical ...
The traditional method of achieving scale in manufacturing is, typically, to increase production capacity so that more product can be sold. For example, with medicines ...
Hitachi Chemical Advanced Therapeutics Solutions (HCATS) is proud to be an active contributor to the scientific research and publications surrounding the regenerative ...
Cell therapy products have started to gain significant traction in the pharmaceutical industry in the last few years because of the potential they possess to treat many ...
From helping prepare clients' cell therapy products for commercial-scale manufacturing to troubleshooting test methods for compliance with cGMP and cGTP regulations, ...
Dr. Robert Preti joins The Cell Culture Dish in advance of his upcoming keynote at CBI's Optimization of Cell and Gene Therapy Production Conference. The Cell Culture ...